Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Industry Drivers and Challenges
2.3: Supply Chain
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Active Pharmaceutical Ingredient Market Trends and Forecast
3.3: MENA Active Pharmaceutical Ingredient Market Trends and Forecast
3.4: MENA Active Pharmaceutical Ingredient Market by Synthesis Type
3.4.1: Synthetic Chemical
3.4.2: Biotech and Biologics
3.4.3: Plant Extracts
3.4.4: Fermentation
3.4.5: Others
3.5: MENA Active Pharmaceutical Ingredient Market by Manufacturer Type
3.5.1: Captive APIs
3.5.2: Merchant APIs
3.6: MENA Active Pharmaceutical Ingredient Market by Therapeutic Area
3.6.1: Cardiology
3.6.2: Oncology
3.6.3: Neurology
3.6.4: Orthopedics
3.6.5: Ophthalmology
3.6.6: Pulmonology
3.6.7: Aliment
3.6.8: Anti-Inflammatory
3.6.9: Others
3.7: MENA Active Pharmaceutical Ingredient Market by Product Form
3.7.1: Liquid APIs
3.7.2: Powder APIs
3.8: MENA Active Pharmaceutical Ingredient Market by Molecule
3.8.1: Large Molecules
3.8.2: Small Molecules
3.9: MENA Active Pharmaceutical Ingredient Market by Drug Type
3.9.1: Branded
3.9.2: Generic
3.9.3: Over-the–Counter (OTC)
3.10: Saudi Arabian Active Pharmaceutical Ingredient Market
3.10.1: Market by Therapeutic Area: Cardiology, Oncology, Neurology, Orthopedics, Ophthalmology, Aliment, Anti-Inflammatory, and Others
4. Competitor Analysis
4.1: Product Portfolio Analysis
4.2: Market Share Analysis
4.3: Operational Integration
4.4: Geographical Reach
4.5: Porter’s Five Forces Analysis
5. Growth Opportunities and Strategic Analysis
5.1: Growth Opportunity Analysis
5.1.1: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Synthesis Type
5.1.2: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Manufacturer Type
5.1.3: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Therapeutic Area
5.1.4: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Product Form
5.1.5: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Molecule
5.1.6: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Drug Type
5.2: Emerging Trends in the MENA Active Pharmaceutical Ingredient Market
5.3: Strategic Analysis
5.3.1: New Technological Development
5.3.2: Mergers, Acquisitions, and Joint Ventures in the MENA Active Pharmaceutical Ingredient Market
5.3.3: Capacity Expansion of the MENA Active Pharmaceutical Ingredient Market
5.3.4: Certification and Licensing
6. Company Profiles of Leading Players
6.1: Pfizer Inc.
6.2: Teva Pharmaceutical Industries Ltd.
6.3: GlaxoSmithKline (GSK)
6.4: Sun Pharmaceutical Industries Ltd.
6.5: Novartis International AG
6.6: Aurobindo Pharma Ltd.
6.7: Merck & Co.
6.8: BASF SE
6.9: Julphar Pharmaceutical Company
6.10: AbbVie Inc.
List of Figures
Chapter 2. Market Background and Classifications
Figure 2.1: Active Pharmaceutical Ingredient
Figure 2.2: Classification of the Active Pharmaceutical Ingredient Market
Figure 2.3: Major Drivers and Challenges for the MENA Active Pharmaceutical Ingredient Market
Figure 2.4: Supply Chain of the MENA Active Pharmaceutical Ingredient Market
Chapter 3. Market Trends and Forecast Analysis from 2014 to 2025
Figure 3.1: Trends and Forecast for the MENA GDP Growth Rate
Figure 3.2: Trends and Forecast for the MENA Population Growth Rate
Figure 3.3: Trends and Forecast for the MENA Inflation Rate
Figure 3.4: Trends and Forecast for the MENA Unemployment Rate
Figure 3.5: Trends and Forecast for the MENA Per Capita Income
Figure 3.6: Trends and Forecast for the Global Active Pharmaceutical Ingredient Market (2014-2025)
Figure 3.7: Trends and Forecast for the MENA Active Pharmaceutical Ingredient Market (2014-2025)
Figure 3.8: Trends of the MENA Active Pharmaceutical Ingredient Market ($M) by Synthesis Type (2014-2019)
Figure 3.9: Forecast for the MENA Active Pharmaceutical Ingredient Market ($M) by Synthesis Type (2020-2025)
Figure 3.10: Trends of Synthetic Chemical in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.11: Forecast for Synthetic Chemical in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.12: Trends of Biotech and Biologics in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.13: Forecast for Biotech and Biologics in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.14: Trends of Plant Extracts in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.15: Forecast for Plant Extracts in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.16: Trends of Fermentation in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.17: Forecast for Fermentation in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.18: Trends of Other Synthesis Type in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.19: Forecast for Other Synthesis Type in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.20: Trends of the MENA Active Pharmaceutical Ingredient Market ($M) by Manufacturer Type (2014- 2019)
Figure 3.21: Forecast for the MENA Active Pharmaceutical Ingredient Market ($M) by Manufacturer Type (2020-2025)
Figure 3.22: Trends of Captive APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.23: Forecast for Captive APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.24: Trends of Merchant APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.25: Forecast for Merchant APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.26: Trends of the MENA Active Pharmaceutical Ingredient Market ($M) by Therapeutic Area (2014-2019)
Figure 3.27: Forecast for the MENA Active Pharmaceutical Ingredient Market ($M) by Therapeutic Area (2020-2025)
Figure 3.28: Trends of Cardiology in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.29: Forecast for Cardiology in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.30: Trends of Oncology in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.31: Forecast for Oncology in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.32: Trends of Neurology in the MENA Active Pharmaceutical Ingredient ($M) (2014-2019)
Figure 3.33: Forecast for Neurology in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.34: Trends of Orthopedics in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.35: Forecast for Orthopedics in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.36: Trends of Ophthalmology in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.37: Forecast for Ophthalmology in the MENA Active Pharmaceutical Ingredient Market ($M) by Region (2020-2025)
Figure 3.38: Trends of Pulmonology in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.39: Forecast for Pulmonology in the MENA Active Pharmaceutical Ingredient Market ($M) by Region (2020-2025)
Figure 3.40: Trends of Aliment in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.41: Forecast for Aliment in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.42: Trends of Anti-Inflammatory in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.43: Forecast for Anti-Inflammatory in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.44: Trends of Other Therapeutic Areas in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.45: Forecast for Other Therapeutic Areas in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.46: Trends of the MENA Active Pharmaceutical Ingredient Market ($M) by Product Form (2014-2019)
Figure 3.47: Forecast for the MENA Active Pharmaceutical Ingredient Market ($M) by Product Form (2020-2025)
Figure 3.48: Trends of Liquid APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.49: Forecast for Liquid APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.50: Trends of Powder APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.51: Forecast for Powder APIs in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.52: Trends of the MENA Active Pharmaceutical Ingredient Market ($M) by Molecule (2014-2019)
Figure 3.53: Forecast for the MENA Active Pharmaceutical Ingredient Market ($M) by Molecule (2020-2025)
Figure 3.54: Trends of Large Molecules in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.55: Forecast for Large Molecules in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.56: Trends of Small Molecules in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.57: Forecast for Small Molecules in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.58: Trends of the MENA Active Pharmaceutical Ingredient Market ($M) by Drug Type (2014- 2019)
Figure 3.59: Forecast for the MENA Active Pharmaceutical Ingredient Market ($M) by Drug Type (2020-2025)
Figure 3.60: Trends of Branded in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.61: Forecast for Branded in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.62: Trends of Generic in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.63: Forecast for Generic in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.64: Trends of Over-the-Counter in the MENA Active Pharmaceutical Ingredient Market ($M) (2014-2019)
Figure 3.65: Forecast for Over-the-Counter in the MENA Active Pharmaceutical Ingredient Market ($M) (2020-2025)
Figure 3.66: Trends and Forecast for the Saudi Arabian Active Pharmaceutical Ingredient Market (2014-2025)
Figure 3.67: Trends of the Saudi Arabian Active Pharmaceutical Ingredient Market ($M) by Therapeutic Area (2014-2019)
Figure 3.68: Forecast for the Saudi Arabian Active Pharmaceutical Ingredient Market ($M) by Therapeutic Area (2020-2025)
Table 3.69: Market Size and CAGR of Various Therapeutic Areas of the Saudi Arabian Active Pharmaceutical Ingredient Market by Value (2014-2019)
Chapter 4. Competitor Analysis
Figure 4.1: Market Share Analysis of the MENA API Market in 2019
Figure 4.2: Market Share Analysis of Top Five Players in the MENA API Market in 2019
Figure 4.3: Major Locations of Competitors in the MENA Active Pharmaceutical Ingredient Market
Figure 4.4: Porter’s Five Forces Analysis of the MENA Active Pharmaceutical Ingredient Market
Chapter 5. Growth Opportunities and Strategic Analysis
Figure 5.1: Growth Opportunities for the MENA Active Pharmaceutical Ingredient Market by Synthesis Type (2020-2025)
Figure 5.2: Growth Opportunities for the MENA Active Pharmaceutical Ingredient Market by Manufacturer Type (2020-2025)
Figure 5.3: Growth Opportunities for the MENA Active Pharmaceutical Ingredient Market by Therapeutic Area (2020-2025)
Figure 5.4: Growth Opportunities for the MENA Active Pharmaceutical Ingredient Market by Product Form (2020-2025)
Figure 5.5: Growth Opportunities for the MENA Active Pharmaceutical Ingredient Market by Molecule (2020-2025)
Figure 5.6: Growth Opportunities for the MENA Active Pharmaceutical Ingredient Market by Drug Type (2020-2025)
Figure 5.7: Emerging Trends in the MENA Active Pharmaceutical Ingredient Market
Figure 5.8: Major Capacity Expansions in the MENA Active Pharmaceutical Ingredient Market (2014-2019)
Chapter 6. Company Profiles of Leading Players
Figure 6.1: Headquarter Location of Pfizer Inc.
Figure 6.2: Headquarter Location of Teva Pharmaceutical Industries Ltd.
Figure 6.3: Headquarter Location of GlaxoSmithKline (GSK)
Figure 6.4: Manufacturing Location of Sun Pharmaceutical Industries Ltd.
Figure 6.5: Headquarter Location of Novartis International AG.
Figure 6.6: Headquarter Location of Aurobindo Pharma Ltd.
Figure 6.7: Headquarter Location of Merck & Co.
Figure 6.8: Headquarter Location of BASF SE
Figure 6.9: Headquarter Locations of Julphar Pharmaceutical Company
Figure 6.10: Headquarter Location of AbbVie Inc.
List of Tables
Chapter 1. Executive Summary
Table 1.1: MENA Active Pharmaceutical Ingredient Market Parameters and Attributes
Chapter 3. Market Trends and Forecast Analysis from 2014 to 2025
Table 3.1: Market Trends of the Global Active Pharmaceutical Ingredient Market (2014-2019)
Table 3.2: Market Forecast for the Global Active Pharmaceutical Ingredient Market (2020-2025)
Table 3.3: Market Trends of the MENA Active Pharmaceutical Ingredient Market (2014-2019)
Table 3.4: Market Forecast for the MENA Active Pharmaceutical Ingredient Market (2020-2025)
Table 3.5: Market Size and CAGR of Various Synthesis Types in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.6: Market Size and CAGR of Various Synthesis Types of the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.7: Market Size and CAGR of Synthetic Chemical in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.8: Market Size and CAGR of Synthetic Chemical in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.9: Market Size and CAGR of Biotech and Biologics in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.10: Market Size and CAGR of Biotech and Biologics in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.11: Market Size and CAGR of Plant Extracts in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.12: Market Size and CAGR of Plant Extracts in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.13: Market Size and CAGR of Fermentation in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.14: Market Size and CAGR of Fermentation in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.15: Market Size and CAGR of Other Synthesis Type in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.16: Market Size and CAGR Other Synthesis Type in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.17: Market Size and CAGR of Various Manufacturer Types in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.18: Market Size and CAGR of Various Manufacturer Types in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.19: Market Size and CAGR of Captive APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.20: Market Size and CAGR of Captive APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.21: Market Size and CAGR of Merchant APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.22: Market Size and CAGR of Merchant APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.23: Market Size and CAGR of Various Therapeutic Areas in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.24: Market Size and CAGR of Various Therapeutic Areas in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.25: Market Size and CAGR of Cardiology in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.26: Market Size and CAGR of Cardiology in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.27: Market Size and CAGR of Oncology in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.28: Market Size and CAGR of Oncology in the MENA Active Pharmaceutical Ingredient Market (2020-2025)
Table 3.29: Market Size and CAGR of Neurology in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.30: Market Size and CAGR of Neurology in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.31: Market Size and CAGR of Orthopedics in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.32: Market Size and CAGR of Orthopedics in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.33: Market Size and CAGR of Ophthalmology in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.34: Market Size and CAGR of Ophthalmology in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.35: Market Size and CAGR of Pulmonology in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.36: Market Size and CAGR of Pulmonology in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.37: Market Size and CAGR of Aliment in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.38: Market Size and CAGR of Aliment in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.39: Market Size and CAGR of Anti-Inflammatory in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.40: Market Size and CAGR of Anti-Inflammatory in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.41: Market Size and CAGR of Other Therapeutic Areas in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.42: Market Size and CAGR of Other therapeutic Areas in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.43: Market Size and CAGR of Various Product Forms in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.44: Market Size and CAGR of Various Product Forms in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.45: Market Size and CAGR of Liquid APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.46: Market Size and CAGR of Liquid APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.47: Market Size and CAGR of Powder APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.48: Market Size and CAGR of Powder APIs in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.49: Market Size and CAGR of Various Molecules in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.50: Market Size and CAGR of Various Molecules in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.51: Market Size and CAGR of Large Molecules in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.52: Market Size and CAGR of Large Molecules in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.53: Market Size and CAGR of Small Molecules in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.54: Market Size and CAGR of Small Molecules in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.55: Market Size and CAGR of Various Drug Types in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.56: Market Size and CAGR of Various Drug Types of the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.57: Market Size and CAGR of Branded in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.58: Market Size and CAGR of Branded in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.59: Market Size and CAGR of Generic in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.60: Market Size and CAGR of Generic in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.61: Market Size and CAGR of Over-the-Counter in the MENA Active Pharmaceutical Ingredient Market by Value (2014-2019)
Table 3.62: Market Size and CAGR of Over-the-Counter in the MENA Active Pharmaceutical Ingredient Market by Value (2020-2025)
Table 3.63: Market Trends of the Saudi Arabian Active Pharmaceutical Ingredient Market (2014-2019)
Table 3.64: Market Forecast for the Saudi Arabian Active Pharmaceutical Ingredient Market (2020-2025)
Table 3.65: Market Size and CAGR of Various Therapeutic Areas of the Saudi Arabian Active Pharmaceutical Ingredient Market by Value (2020-2025)
Chapter 4. Competitor Analysis
Table 4.1: Product Mapping of MENA Active Pharmaceutical Ingredient Suppliers Based on Markets Served
Table 4.2: Rankings of Public Suppliers Based on the MENA API Market Revenue
Table 4.3: Operational Integration of MENA API Suppliers
Chapter 5. Growth Opportunities and Strategic Analysis
Table 5.1: New Technological Developments by Major Active Pharmaceutical Ingredient Manufacturers (2014-2019) (Source: Lucintel)
Table 5.2: Certifications and Licenses Acquired by Major Competitors in the MENA Active Pharmaceutical Ingredient Market